Neurosense Therapeutics' (NRSN) PrimeC Demonstrates Outstanding Effect on ALS Survival in Innovative iPSC Model streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
In collaboration with the University of Southern California s Ichida Stem Cell Lab, PrimeC was shown to significantly increase survival rate of induced motor neurons in an in vitro study utilizing.
"I regret to announce that we have lost our first doctor, Dr. Mohammed Ali, a Tanzanian national, 37-year-old Male," the health minister, Jane Ruth Aceng, tweeted. Moderna refused China request to reveal vaccine technology - FT Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter.
Amylyx Pharmaceuticals on Friday set the list price of its newly approved drug to treat amyotrophic lateral sclerosis (ALS) at about $158,000 per year in the United States, a discount to its most recently approved competitor.